Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
NINDS Exploratory/Developmental Projects in Translational Research (R21)
Release Date: August 12, 2008
Announcement Number: PAR-08-232
Application Receipt Date:
October 16, 2008
February 16, 2009
June 16, 2009
October 16, 2009
February 16, 2010
June 16, 2010
October 16, 2010
February 16, 2011
June 16, 2011
Funding Contact: Thomas Miller, Ph.D., M.B.A.
Program Area: Office of Translational Research
Brief Description:
This Funding Opportunity Announcement (FOA) requests applications for projects intended to complete preliminary steps in the
pipeline for the pre-clinical development of therapeutics for neurological disorders. Such projects, if successful, should
lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New
Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required
for therapy development can be supported in this program. This program excludes clinical research, basic research and studies
of disease mechanism.
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |